Aviva’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $57M | Buy |
91,486
+310
| +0.3% | +$211K | 0.08% | 223 |
|
|
2026
Q1 | $70.4M | Buy |
91,176
+2,537
| +3% | +$1.94M | 0.12% | 174 |
|
|
2025
Q4 | $68.4M | Buy |
88,639
+4,357
| +5% | +$2.96M | 0.12% | 164 |
|
|
2025
Q3 | $47.4M | Buy |
84,282
+4,397
| +6% | +$2.49M | 0.09% | 221 |
|
|
2025
Q2 | $41.9M | Buy |
79,885
+4,525
| +6% | +$2.53M | 0.09% | 226 |
|
|
2025
Q1 | $47.8M | Buy |
75,360
+10,220
| +16% | +$7.03M | 0.12% | 200 |
|
|
2024
Q4 | $46.4M | Buy |
65,140
+6,222
| +11% | +$5.22M | 0.12% | 184 |
|
|
2024
Q3 | $61.9M | Buy |
58,918
+1,548
| +3% | +$1.72M | 0.16% | 144 |
|
|
2024
Q2 | $60.3M | Buy |
57,370
+10,081
| +21% | +$9.77M | 0.17% | 120 |
|
|
2024
Q1 | $45.5M | Buy |
47,289
+5,921
| +14% | +$5.63M | 0.15% | 133 |
|
|
2023
Q4 | $36.3M | Sell |
41,368
-3,524
| -8% | -$2.9M | 0.13% | 183 |
|
|
2023
Q3 | $36.9M | Buy |
44,892
+15,207
| +51% | +$12M | 0.16% | 126 |
|
|
2023
Q2 | $21.3M | Buy |
29,685
+7,517
| +34% | +$5.8M | 0.09% | 286 |
|
|
2023
Q1 | $18.2M | Sell |
22,168
-14,697
| -40% | -$11.1M | 0.08% | 357 |
|
|
2022
Q4 | $26.6M | Sell |
36,865
-943
| -2% | -$696K | 0.13% | 200 |
|
|
2022
Q3 | $26M | Sell |
37,808
-1,319
| -3% | -$830K | 0.15% | 165 |
|
|
2022
Q2 | $23.1M | Buy |
39,127
+12,402
| +46% | +$8.06M | 0.12% | 214 |
|
|
2022
Q1 | $18.7M | Sell |
26,725
-4,505
| -14% | -$2.85M | 0.09% | 263 |
|
|
2021
Q4 | $19.7M | Buy |
31,230
+549
| +2% | +$338K | 0.08% | 232 |
|
|
2021
Q3 | $18.6M | Sell |
30,681
-1,550
| -5% | -$962K | 0.08% | 242 |
|
|
2021
Q2 | $18M | Buy |
32,231
+101
| +0.3% | +$51.2K | 0.08% | 254 |
|
|
2021
Q1 | $15.2M | Buy |
32,130
+287
| +0.9% | +$140K | 0.07% | 240 |
|
|
2020
Q4 | $15.4M | Buy |
31,843
+697
| +2% | +$376K | 0.08% | 230 |
|
|
2020
Q3 | $17.4M | Sell |
31,146
-848
| -3% | -$514K | 0.1% | 179 |
|
|
2020
Q2 | $20M | Buy |
31,994
+12,988
| +68% | +$7.37M | 0.12% | 143 |
|
|
2020
Q1 | $9.28M | Sell |
19,006
-466
| -2% | -$192K | 0.07% | 251 |
|
|
2019
Q4 | $7.31M | Sell |
19,472
-935
| -5% | -$315K | 0.04% | 358 |
|
|
2019
Q3 | $5.66M | Sell |
20,407
-9,704
| -32% | -$2.87M | 0.04% | 386 |
|
|
2019
Q2 | $9.43M | Sell |
30,111
-311
| -1% | -$104K | 0.06% | 283 |
|
|
2019
Q1 | $12.5M | Buy |
30,422
+386
| +1% | +$159K | 0.08% | 239 |
|
|
2018
Q4 | $11.2M | Sell |
30,036
-8,362
| -22% | -$3.06M | 0.08% | 241 |
|
|
2018
Q3 | $15.5M | Sell |
38,398
-1,531
| -4% | -$583K | 0.09% | 246 |
|
|
2018
Q2 | $13.8M | Sell |
39,929
-368
| -0.9% | -$115K | 0.08% | 248 |
|
|
2018
Q1 | $13.9M | Sell |
40,297
-3,923
| -9% | -$1.36M | 0.08% | 242 |
|
|
2017
Q4 | $16.6M | Sell |
44,220
-5,626
| -11% | -$2.28M | 0.09% | 234 |
|
|
2017
Q3 | $22.3M | Sell |
49,846
-90
| -0.2% | -$42.8K | 0.12% | 200 |
|
|
2017
Q2 | $24.5M | Sell |
49,936
-1,120
| -2% | -$490K | 0.14% | 172 |
|
|
2017
Q1 | $19.8M | Sell |
51,056
-2,247
| -4% | -$833K | 0.11% | 206 |
|
|
2016
Q4 | $19.6M | Buy |
53,303
+3,303
| +7% | +$1.26M | 0.12% | 200 |
|
|
2016
Q3 | $20.1M | Buy |
50,000
+545
| +1% | +$219K | 0.13% | 194 |
|
|
2016
Q2 | $17.3M | Buy |
49,455
+4,646
| +10% | +$1.79M | 0.12% | 199 |
|
|
2016
Q1 | $16.2M | Buy |
44,809
+1,297
| +3% | +$534K | 0.12% | 186 |
|
|
2015
Q4 | $23.6M | Sell |
43,512
-112
| -0.3% | -$60.7K | 0.18% | 126 |
|
|
2015
Q3 | $20.3M | Sell |
43,624
-941
| -2% | -$505K | 0.17% | 147 |
|
|
2015
Q2 | $22.7M | Buy |
44,565
+2,110
| +5% | +$1.03M | 0.16% | 150 |
|
|
2015
Q1 | $19.2M | Buy |
42,455
+10,881
| +34% | +$4.61M | 0.13% | 178 |
|
|
2014
Q4 | $13M | Buy |
31,574
+110
| +0.3% | +$43.3K | 0.1% | 238 |
|
|
2014
Q3 | $11.3M | Buy |
31,464
+30
| +0.1% | +$10.1K | 0.09% | 249 |
|
|
2014
Q2 | $8.88M | Sell |
31,434
-70
| -0.2% | -$20.7K | 0.07% | 323 |
|
|
2014
Q1 | $9.46M | Buy |
31,504
+1,890
| +6% | +$582K | 0.08% | 287 |
|
|
2013
Q4 | $8.15M | Buy |
29,614
+1,605
| +6% | +$462K | 0.07% | 318 |
|
|
2013
Q3 | $8.76M | Buy |
28,009
+7,405
| +36% | +$1.95M | 0.08% | 277 |
|
|
2013
Q2 | $4.63M | Buy |
+20,604
| New | +$4.8M | 0.05% | 369 |
|
Other funds holding REGN
Aviva's REGN Position: Q2 2026 in Review
Aviva increased its Regeneron Pharmaceuticals (REGN) stake by 0.34% in Q2 2026, buying an estimated $211K and bringing the position to 91,486 shares worth $57M. The position accounts for 0.08% of the portfolio, ranked #223.
Aviva first reported a position in REGN in Q2 2013 and has held it in 53 quarters since. The position peaked at $70.4M in Q1 2026. 1,332 funds tracked by Wall St. Rank hold REGN as of Q2 2026.
- Aviva held 91,486 shares of Regeneron Pharmaceuticals worth $57M as of Q2 2026.
- Aviva bought 310 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $211K.
- Regeneron Pharmaceuticals made up 0.08% of Aviva's portfolio in Q2 2026, its #223 holding.
- Aviva first reported a position in Regeneron Pharmaceuticals in Q2 2013 and has held it in 53 quarters since.
- Aviva's Regeneron Pharmaceuticals position peaked at $70.4M in Q1 2026.
- 1,332 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.
Based on Aviva's 13F filing for Q2 2026, filed 13 Aug 2026.